Given the current focus on immunosuppressive molecules within the tumor microenvironment, we speculated whether T cells might be hindered in their anti-tumor capacity by such molecules, such as PD-L1, expressed on tumor VECs during their initial entry into the tumor vasculature. Here, CD274 is linked to neoplasm.